Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayesh Mehta

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Total therapy 2 in treatment of multiple myeloma: questions about gene expression profiling and treatment-related mortalityJayesh Mehta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Myeloid growth factors should not be administered routinely after allogeneic hematopoietic stem-cell transplantationJayesh Mehta
Blood|May 27, 2008
Cytomegalovirus: time for a requiem?Jayesh Mehta
Cancer Treatment and Research|October 8, 2005
Cytokines in hematopoietic stem cell transplantationJayesh Mehta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Sirolimus-containing graft-versus-host disease prophylaxis in patients with lymphomaJayesh Mehta
The New England Journal of Medicine|June 9, 2021
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaJayesh Mehta
Lancet (London, England)|March 25, 2008
Treatment for elderly patients with multiple myelomaJayesh Mehta
Blood|March 26, 2008
One or two autografts for myeloma?Jayesh Mehta
The New England Journal of Medicine|November 19, 2002
Varicella vaccine in recipients of hematopoietic-cell transplantsJayesh Mehta
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2011
Age and the outcome of allogeneic hematopoietic stem cell transplantation: was Tacitus wrong?Jayesh Mehta
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Total therapy 2 in treatment of multiple myeloma: questions about gene expression profiling and treatment-related mortalityJayesh Mehta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Myeloid growth factors should not be administered routinely after allogeneic hematopoietic stem-cell transplantationJayesh Mehta
Blood|May 27, 2008
Cytomegalovirus: time for a requiem?Jayesh Mehta
Cancer Treatment and Research|October 8, 2005
Cytokines in hematopoietic stem cell transplantationJayesh Mehta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Sirolimus-containing graft-versus-host disease prophylaxis in patients with lymphomaJayesh Mehta
The New England Journal of Medicine|June 9, 2021
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaJayesh Mehta
Lancet (London, England)|March 25, 2008
Treatment for elderly patients with multiple myelomaJayesh Mehta
Blood|March 26, 2008
One or two autografts for myeloma?Jayesh Mehta
The New England Journal of Medicine|November 19, 2002
Varicella vaccine in recipients of hematopoietic-cell transplantsJayesh Mehta
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2011
Age and the outcome of allogeneic hematopoietic stem cell transplantation: was Tacitus wrong?Jayesh Mehta
Pageof 11